NuvOx Pharma is a clinical stage pharmaceutical company based in Tucson, Arizona, dedicated to reversing hypoxia, a condition where the body's cells lack sufficient oxygen, which is a significant factor in various life-threatening diseases. Their mission is to ensure patient safety and provide access to life-saving oxygen therapeutics.
With a team of industry pioneers and scientists, NuvOx Pharma is focused on developing a first-in-class oxygen therapeutic drug that enhances the flow of oxygen from the lungs to the blood and from the blood to the tissues. Their consistent results, demonstrated through over 30 animal studies and Phase Ib II clinical trials in stroke and oncology, have shown both safety and evidence of efficacy, leading to their upcoming trial in COVID-19 patients with Acute Hypoxemic Respiratory Failure (AHRF).
Generated from the website